| |
| | Final Diagnosis -- Case 241 |
 | | The condition is diagnosed in approximately 1,500 individuals annually in the U.S., and is usually not detected until either the paraprotein level exceeds 3.0 g/dL (1,2), or until the blood viscosity is at least four times that of normal serum (2). |
 | | The serum IgM paraprotein, although decreased, was still present after 21 months of chemotherapy; and the patient still had residual hematuria suggestive of persistent glomerular damage. |
 | | In cases with hyperviscosity syndrome, chemotherapy is recommended to aid in rapidly decreasing the paraprotein level, and to target and control the underlying lymphoproliferative disorder. |
| path.upmc.edu /cases/case241/dx.html (1191 words) |
|